Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2-(2-chlorophenyl)-4-(3-(dimethylamino)phenyl)-5-methyl-1h-pyrazolo(4,3-c)pyridine-3,6(2h,5h)-dione
2. Gkt-137831
3. Gkt-831
4. Gkt137831
5. Setanaxib
1. 1218942-37-0
2. Gkt137831
3. Setanaxib
4. Gkt-137831
5. Gkt-831
6. Gkt831
7. 2-(2-chlorophenyl)-4-(3-(dimethylamino)phenyl)-5-methyl-1h-pyrazolo(4,3-c)pyridine-3,6(2h,5h)-dione
8. 2-(2-chlorophenyl)-4-[3-(dimethylamino)phenyl]-5-methyl-1h-pyrazolo[4,3-c]pyridine-3,6-dione
9. 45ii35329v
10. 2-(2-chlorophenyl)-4-(3-(dimethylamino)phenyl)-5-methyl-1,2-dihydro-3h-pyrazolo[4,3-c]pyridine-3,6(5h)-dione
11. Unii-45ii35329v
12. 1h-pyrazolo(4,3-c)pyridine-3,6(2h,5h)-dione, 2-(2-chlorophenyl)-4-(3-(dimethylamino)phenyl)-5-methyl-
13. 1h-pyrazolo[4,3-c]pyridine-3,6(2h,5h)-dione, 2-(2-chlorophenyl)-4-[3-(dimethylamino)phenyl]-5-methyl-
14. Gkt 137831
15. Setanaxib [inn]
16. Gtpl9932
17. Schembl1302603
18. Chembl4303187
19. Dtxsid30153432
20. Ex-a577
21. Bcp14159
22. Mfcd27923122
23. S7171
24. Zinc95670835
25. Akos022176138
26. Ccg-268595
27. Cs-3290
28. Sb19230
29. Ncgc00378460-05
30. Ncgc00378460-08
31. Ncgc00378460-09
32. Ac-33132
33. As-74753
34. Da-33605
35. Hy-12298
36. Ft-0700121
37. A14433
38. J-690070
39. Q27258840
40. 2-(2-chlorophenyl)-4-[3-(dimethylamino)phenyl]-5-methyl-1h,2h,3h,5h,6h-pyrazolo[4,3-c]pyridine-3,6-dione
41. 2-(2-chlorophenyl)-4-[3-(dimethylamino)phenyl]-5-methylpyrazolo[4,3-c]pyridine-3,6(2h,5h)-dione
| Molecular Weight | 394.9 g/mol |
|---|---|
| Molecular Formula | C21H19ClN4O2 |
| XLogP3 | 3.2 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 3 |
| Exact Mass | 394.1196536 g/mol |
| Monoisotopic Mass | 394.1196536 g/mol |
| Topological Polar Surface Area | 55.9 Ų |
| Heavy Atom Count | 28 |
| Formal Charge | 0 |
| Complexity | 732 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Setanaxib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Setanaxib, including repackagers and relabelers. The FDA regulates Setanaxib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Setanaxib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Setanaxib supplier is an individual or a company that provides Setanaxib active pharmaceutical ingredient (API) or Setanaxib finished formulations upon request. The Setanaxib suppliers may include Setanaxib API manufacturers, exporters, distributors and traders.
Setanaxib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Setanaxib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Setanaxib GMP manufacturer or Setanaxib GMP API supplier for your needs.
A Setanaxib CoA (Certificate of Analysis) is a formal document that attests to Setanaxib's compliance with Setanaxib specifications and serves as a tool for batch-level quality control.
Setanaxib CoA mostly includes findings from lab analyses of a specific batch. For each Setanaxib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Setanaxib may be tested according to a variety of international standards, such as European Pharmacopoeia (Setanaxib EP), Setanaxib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Setanaxib USP).
LOOKING FOR A SUPPLIER?
